Continuous Manufacturing Technology To Existing Process: Challenge And Advantage Of Implementing N-1 Perfusion Technology

In this presentation, Thomas Gervais, Ph.D., Head of Manufacturing Sciences and Technology, Samsung Biologics, discusses key considerations and challenges in implementing N-1 perfusion technology as well as the impact of continuous technology on tech transfer and process scale-up.

The presentation includes:

• Impact of continuous technology on tech transfer and process scale-up
• Key considerations and challenges in N-1 perfusion to meet reduced cell culture duration and higher protein titers in the overall product yield
• Real case: Before vs After implementing N-1 technology
• Preparing for next plan for continuous process intensification